or Try an Advanced Search...

    Technical Analysis for EVO - Evotec SE

    Grade Last Price % Change Price Change
    F 5.19 0.97% 0.05
    EVO closed up 0.97 percent on Wednesday, May 8, 2024, on 32 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical EVO trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 0.97%
    Narrow Range Bar Range Contraction 0.97%
    Wide Bands Range Expansion 0.97%
    Down 3 Days in a Row Weakness 0.97%
    Oversold Stochastic Weakness 0.97%
    Narrow Range Bar Range Contraction -0.19%
    Wide Bands Range Expansion -0.19%
    Older End-of-Day Signals for EVO ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 10 hours ago
    Rose Above Previous Day's High about 11 hours ago
    Rose Above 10 DMA about 11 hours ago
    Up 1% about 11 hours ago
    60 Minute Opening Range Breakout about 12 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    EVO Chart by TradingView
    Basic chart:

    Profile

    Evotec is an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry. Evotec's mission is to discover best and first-in-class medicines for a broad range of difficult to treat diseases in collaboration with our partners. Evotec has built a comprehensive suite of fully integrated, next generation technology platforms which it believes will transform the way new drugs are discovered. By leveraging the advanced capabilities of Evotec's integrated platforms, Evotec is able to provide solutions to its partners that enable significant improvements in the quality of new drugs while accelerating the drug discovery process and reducing the high cost of attrition often associated with traditional drug discovery processes.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Biotechnology Life Sciences Disease Health Sciences Drugs Natural Sciences Medication Drug Discovery Evotec

    Is EVO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 2 3 Growth Stocks to Buy at 52-Week Lows
    Apr 30 Bayer and Evotec Collaborate to Advance Precision Cardiology
    Apr 26 Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript
    Apr 26 Evotec SE (ETR:EVT) Yearly Results: Here's What Analysts Are Forecasting For This Year
    Apr 25 Evotec Full Year 2023 Earnings: EPS Misses Expectations
    Apr 24 Evotec SE (EVO) Q4 2023 Earnings Call Transcript
    Apr 24 Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Apr 24 Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast
    Apr 24 Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
    Apr 24 Evotec SE 2023 Q4 - Results - Earnings Call Presentation
    See more EVO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.4924
    52 Week Low 4.8701
    Average Volume 128,979
    200-Day Moving Average 9.19
    50-Day Moving Average 6.87
    20-Day Moving Average 6.12
    10-Day Moving Average 5.19
    Average True Range 0.29
    RSI (14) 31.51
    ADX 29.06
    +DI 21.30
    -DI 45.00
    Chandelier Exit (Long, 3 ATRs) 7.05
    Chandelier Exit (Short, 3 ATRs) 5.74
    Upper Bollinger Bands 8.17
    Lower Bollinger Band 4.06
    Percent B (%b) 0.27
    BandWidth 67.11
    MACD Line -0.59
    MACD Signal Line -0.53
    MACD Histogram -0.0655
    Fundamentals Value
    Market Cap 1.84 Billion
    Num Shares 354 Million
    EPS -0.29
    Price-to-Earnings (P/E) Ratio -17.90
    Price-to-Sales 3.26
    Price-to-Book 2.21
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.33
    Resistance 3 (R3) 5.32 5.28 5.30
    Resistance 2 (R2) 5.28 5.24 5.28 5.29
    Resistance 1 (R1) 5.23 5.22 5.26 5.24 5.29
    Pivot Point 5.19 5.19 5.20 5.19 5.19
    Support 1 (S1) 5.14 5.15 5.17 5.15 5.09
    Support 2 (S2) 5.10 5.13 5.10 5.09
    Support 3 (S3) 5.05 5.10 5.08
    Support 4 (S4) 5.06